Request for Covid-19 Impact Assessment of this Report
The United States Oral Drug Delivery market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Oral Drug Delivery market, reaching US$ million by the year 2028. As for the Europe Oral Drug Delivery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Oral Drug Delivery players cover AstraZeneca Plc., Mylan N.V., Sanofi, and F. Hoffman-La-Roche Ltd., etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Oral Drug Delivery market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Diffusion Controlled Release System
Dissolution Controlled Release System
Ion Exchange Resins Controlled Release
Hydro-dynamically Balanced Drug Delivery System
Osmotically Controlled Release System
Dissolution & Diffusion Controlled Release System
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
AstraZeneca Plc.
Mylan N.V.
Sanofi
F. Hoffman-La-Roche Ltd.
Bristol-Myers Squibb Company
Sun Pharmaceuticals Industries Ltd
Abbott Laboratories
Merck & Co. Inc.
Novartis AG
Pfizer Inc.
Vectura Group plc.
GlaxoSmithKline plc.
Johnson & Johnson Services, Inc
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Oral Drug Delivery Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Oral Drug Delivery by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Oral Drug Delivery by Country/Region, 2017, 2022 & 2028
2.2 Oral Drug Delivery Segment by Type
2.2.1 Diffusion Controlled Release System
2.2.2 Dissolution Controlled Release System
2.2.3 Ion Exchange Resins Controlled Release
2.2.4 Hydro-dynamically Balanced Drug Delivery System
2.2.5 Osmotically Controlled Release System
2.2.6 Dissolution & Diffusion Controlled Release System
2.3 Oral Drug Delivery Sales by Type
2.3.1 Global Oral Drug Delivery Sales Market Share by Type (2017-2022)
2.3.2 Global Oral Drug Delivery Revenue and Market Share by Type (2017-2022)
2.3.3 Global Oral Drug Delivery Sale Price by Type (2017-2022)
2.4 Oral Drug Delivery Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Other
2.5 Oral Drug Delivery Sales by Application
2.5.1 Global Oral Drug Delivery Sale Market Share by Application (2017-2022)
2.5.2 Global Oral Drug Delivery Revenue and Market Share by Application (2017-2022)
2.5.3 Global Oral Drug Delivery Sale Price by Application (2017-2022)
3 Global Oral Drug Delivery by Company
3.1 Global Oral Drug Delivery Breakdown Data by Company
3.1.1 Global Oral Drug Delivery Annual Sales by Company (2020-2022)
3.1.2 Global Oral Drug Delivery Sales Market Share by Company (2020-2022)
3.2 Global Oral Drug Delivery Annual Revenue by Company (2020-2022)
3.2.1 Global Oral Drug Delivery Revenue by Company (2020-2022)
3.2.2 Global Oral Drug Delivery Revenue Market Share by Company (2020-2022)
3.3 Global Oral Drug Delivery Sale Price by Company
3.4 Key Manufacturers Oral Drug Delivery Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Oral Drug Delivery Product Location Distribution
3.4.2 Players Oral Drug Delivery Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Oral Drug Delivery by Geographic Region
4.1 World Historic Oral Drug Delivery Market Size by Geographic Region (2017-2022)
4.1.1 Global Oral Drug Delivery Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Oral Drug Delivery Annual Revenue by Geographic Region
4.2 World Historic Oral Drug Delivery Market Size by Country/Region (2017-2022)
4.2.1 Global Oral Drug Delivery Annual Sales by Country/Region (2017-2022)
4.2.2 Global Oral Drug Delivery Annual Revenue by Country/Region
4.3 Americas Oral Drug Delivery Sales Growth
4.4 APAC Oral Drug Delivery Sales Growth
4.5 Europe Oral Drug Delivery Sales Growth
4.6 Middle East & Africa Oral Drug Delivery Sales Growth
5 Americas
5.1 Americas Oral Drug Delivery Sales by Country
5.1.1 Americas Oral Drug Delivery Sales by Country (2017-2022)
5.1.2 Americas Oral Drug Delivery Revenue by Country (2017-2022)
5.2 Americas Oral Drug Delivery Sales by Type
5.3 Americas Oral Drug Delivery Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Oral Drug Delivery Sales by Region
6.1.1 APAC Oral Drug Delivery Sales by Region (2017-2022)
6.1.2 APAC Oral Drug Delivery Revenue by Region (2017-2022)
6.2 APAC Oral Drug Delivery Sales by Type
6.3 APAC Oral Drug Delivery Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Oral Drug Delivery by Country
7.1.1 Europe Oral Drug Delivery Sales by Country (2017-2022)
7.1.2 Europe Oral Drug Delivery Revenue by Country (2017-2022)
7.2 Europe Oral Drug Delivery Sales by Type
7.3 Europe Oral Drug Delivery Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Oral Drug Delivery by Country
8.1.1 Middle East & Africa Oral Drug Delivery Sales by Country (2017-2022)
8.1.2 Middle East & Africa Oral Drug Delivery Revenue by Country (2017-2022)
8.2 Middle East & Africa Oral Drug Delivery Sales by Type
8.3 Middle East & Africa Oral Drug Delivery Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Oral Drug Delivery
10.3 Manufacturing Process Analysis of Oral Drug Delivery
10.4 Industry Chain Structure of Oral Drug Delivery
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Oral Drug Delivery Distributors
11.3 Oral Drug Delivery Customer
12 World Forecast Review for Oral Drug Delivery by Geographic Region
12.1 Global Oral Drug Delivery Market Size Forecast by Region
12.1.1 Global Oral Drug Delivery Forecast by Region (2023-2028)
12.1.2 Global Oral Drug Delivery Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Oral Drug Delivery Forecast by Type
12.7 Global Oral Drug Delivery Forecast by Application
13 Key Players Analysis
13.1 AstraZeneca Plc.
13.1.1 AstraZeneca Plc. Company Information
13.1.2 AstraZeneca Plc. Oral Drug Delivery Product Offered
13.1.3 AstraZeneca Plc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 AstraZeneca Plc. Main Business Overview
13.1.5 AstraZeneca Plc. Latest Developments
13.2 Mylan N.V.
13.2.1 Mylan N.V. Company Information
13.2.2 Mylan N.V. Oral Drug Delivery Product Offered
13.2.3 Mylan N.V. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Mylan N.V. Main Business Overview
13.2.5 Mylan N.V. Latest Developments
13.3 Sanofi
13.3.1 Sanofi Company Information
13.3.2 Sanofi Oral Drug Delivery Product Offered
13.3.3 Sanofi Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Sanofi Main Business Overview
13.3.5 Sanofi Latest Developments
13.4 F. Hoffman-La-Roche Ltd.
13.4.1 F. Hoffman-La-Roche Ltd. Company Information
13.4.2 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product Offered
13.4.3 F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 F. Hoffman-La-Roche Ltd. Main Business Overview
13.4.5 F. Hoffman-La-Roche Ltd. Latest Developments
13.5 Bristol-Myers Squibb Company
13.5.1 Bristol-Myers Squibb Company Company Information
13.5.2 Bristol-Myers Squibb Company Oral Drug Delivery Product Offered
13.5.3 Bristol-Myers Squibb Company Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Bristol-Myers Squibb Company Main Business Overview
13.5.5 Bristol-Myers Squibb Company Latest Developments
13.6 Sun Pharmaceuticals Industries Ltd
13.6.1 Sun Pharmaceuticals Industries Ltd Company Information
13.6.2 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product Offered
13.6.3 Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 Sun Pharmaceuticals Industries Ltd Main Business Overview
13.6.5 Sun Pharmaceuticals Industries Ltd Latest Developments
13.7 Abbott Laboratories
13.7.1 Abbott Laboratories Company Information
13.7.2 Abbott Laboratories Oral Drug Delivery Product Offered
13.7.3 Abbott Laboratories Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Abbott Laboratories Main Business Overview
13.7.5 Abbott Laboratories Latest Developments
13.8 Merck & Co. Inc.
13.8.1 Merck & Co. Inc. Company Information
13.8.2 Merck & Co. Inc. Oral Drug Delivery Product Offered
13.8.3 Merck & Co. Inc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Merck & Co. Inc. Main Business Overview
13.8.5 Merck & Co. Inc. Latest Developments
13.9 Novartis AG
13.9.1 Novartis AG Company Information
13.9.2 Novartis AG Oral Drug Delivery Product Offered
13.9.3 Novartis AG Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Novartis AG Main Business Overview
13.9.5 Novartis AG Latest Developments
13.10 Pfizer Inc.
13.10.1 Pfizer Inc. Company Information
13.10.2 Pfizer Inc. Oral Drug Delivery Product Offered
13.10.3 Pfizer Inc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Pfizer Inc. Main Business Overview
13.10.5 Pfizer Inc. Latest Developments
13.11 Vectura Group plc.
13.11.1 Vectura Group plc. Company Information
13.11.2 Vectura Group plc. Oral Drug Delivery Product Offered
13.11.3 Vectura Group plc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 Vectura Group plc. Main Business Overview
13.11.5 Vectura Group plc. Latest Developments
13.12 GlaxoSmithKline plc.
13.12.1 GlaxoSmithKline plc. Company Information
13.12.2 GlaxoSmithKline plc. Oral Drug Delivery Product Offered
13.12.3 GlaxoSmithKline plc. Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 GlaxoSmithKline plc. Main Business Overview
13.12.5 GlaxoSmithKline plc. Latest Developments
13.13 Johnson & Johnson Services, Inc
13.13.1 Johnson & Johnson Services, Inc Company Information
13.13.2 Johnson & Johnson Services, Inc Oral Drug Delivery Product Offered
13.13.3 Johnson & Johnson Services, Inc Oral Drug Delivery Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Johnson & Johnson Services, Inc Main Business Overview
13.13.5 Johnson & Johnson Services, Inc Latest Developments
14 Research Findings and Conclusion
Table 1. Oral Drug Delivery Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Oral Drug Delivery Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Diffusion Controlled Release System
Table 4. Major Players of Dissolution Controlled Release System
Table 5. Major Players of Ion Exchange Resins Controlled Release
Table 6. Major Players of Hydro-dynamically Balanced Drug Delivery System
Table 7. Major Players of Osmotically Controlled Release System
Table 8. Major Players of Dissolution & Diffusion Controlled Release System
Table 9. Global Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 10. Global Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 11. Global Oral Drug Delivery Revenue by Type (2017-2022) & ($ million)
Table 12. Global Oral Drug Delivery Revenue Market Share by Type (2017-2022)
Table 13. Global Oral Drug Delivery Sale Price by Type (2017-2022) & (USD/Unit)
Table 14. Global Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 15. Global Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 16. Global Oral Drug Delivery Revenue by Application (2017-2022)
Table 17. Global Oral Drug Delivery Revenue Market Share by Application (2017-2022)
Table 18. Global Oral Drug Delivery Sale Price by Application (2017-2022) & (USD/Unit)
Table 19. Global Oral Drug Delivery Sales by Company (2020-2022) & (K Units)
Table 20. Global Oral Drug Delivery Sales Market Share by Company (2020-2022)
Table 21. Global Oral Drug Delivery Revenue by Company (2020-2022) ($ Millions)
Table 22. Global Oral Drug Delivery Revenue Market Share by Company (2020-2022)
Table 23. Global Oral Drug Delivery Sale Price by Company (2020-2022) & (USD/Unit)
Table 24. Key Manufacturers Oral Drug Delivery Producing Area Distribution and Sales Area
Table 25. Players Oral Drug Delivery Products Offered
Table 26. Oral Drug Delivery Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 27. New Products and Potential Entrants
Table 28. Mergers & Acquisitions, Expansion
Table 29. Global Oral Drug Delivery Sales by Geographic Region (2017-2022) & (K Units)
Table 30. Global Oral Drug Delivery Sales Market Share Geographic Region (2017-2022)
Table 31. Global Oral Drug Delivery Revenue by Geographic Region (2017-2022) & ($ millions)
Table 32. Global Oral Drug Delivery Revenue Market Share by Geographic Region (2017-2022)
Table 33. Global Oral Drug Delivery Sales by Country/Region (2017-2022) & (K Units)
Table 34. Global Oral Drug Delivery Sales Market Share by Country/Region (2017-2022)
Table 35. Global Oral Drug Delivery Revenue by Country/Region (2017-2022) & ($ millions)
Table 36. Global Oral Drug Delivery Revenue Market Share by Country/Region (2017-2022)
Table 37. Americas Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 38. Americas Oral Drug Delivery Sales Market Share by Country (2017-2022)
Table 39. Americas Oral Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 40. Americas Oral Drug Delivery Revenue Market Share by Country (2017-2022)
Table 41. Americas Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 42. Americas Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 43. Americas Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 44. Americas Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 45. APAC Oral Drug Delivery Sales by Region (2017-2022) & (K Units)
Table 46. APAC Oral Drug Delivery Sales Market Share by Region (2017-2022)
Table 47. APAC Oral Drug Delivery Revenue by Region (2017-2022) & ($ Millions)
Table 48. APAC Oral Drug Delivery Revenue Market Share by Region (2017-2022)
Table 49. APAC Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 50. APAC Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 51. APAC Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 52. APAC Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 53. Europe Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 54. Europe Oral Drug Delivery Sales Market Share by Country (2017-2022)
Table 55. Europe Oral Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 56. Europe Oral Drug Delivery Revenue Market Share by Country (2017-2022)
Table 57. Europe Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 58. Europe Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 59. Europe Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 60. Europe Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 61. Middle East & Africa Oral Drug Delivery Sales by Country (2017-2022) & (K Units)
Table 62. Middle East & Africa Oral Drug Delivery Sales Market Share by Country (2017-2022)
Table 63. Middle East & Africa Oral Drug Delivery Revenue by Country (2017-2022) & ($ Millions)
Table 64. Middle East & Africa Oral Drug Delivery Revenue Market Share by Country (2017-2022)
Table 65. Middle East & Africa Oral Drug Delivery Sales by Type (2017-2022) & (K Units)
Table 66. Middle East & Africa Oral Drug Delivery Sales Market Share by Type (2017-2022)
Table 67. Middle East & Africa Oral Drug Delivery Sales by Application (2017-2022) & (K Units)
Table 68. Middle East & Africa Oral Drug Delivery Sales Market Share by Application (2017-2022)
Table 69. Key Market Drivers & Growth Opportunities of Oral Drug Delivery
Table 70. Key Market Challenges & Risks of Oral Drug Delivery
Table 71. Key Industry Trends of Oral Drug Delivery
Table 72. Oral Drug Delivery Raw Material
Table 73. Key Suppliers of Raw Materials
Table 74. Oral Drug Delivery Distributors List
Table 75. Oral Drug Delivery Customer List
Table 76. Global Oral Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 77. Global Oral Drug Delivery Sales Market Forecast by Region
Table 78. Global Oral Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 79. Global Oral Drug Delivery Revenue Market Share Forecast by Region (2023-2028)
Table 80. Americas Oral Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 81. Americas Oral Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. APAC Oral Drug Delivery Sales Forecast by Region (2023-2028) & (K Units)
Table 83. APAC Oral Drug Delivery Revenue Forecast by Region (2023-2028) & ($ millions)
Table 84. Europe Oral Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 85. Europe Oral Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 86. Middle East & Africa Oral Drug Delivery Sales Forecast by Country (2023-2028) & (K Units)
Table 87. Middle East & Africa Oral Drug Delivery Revenue Forecast by Country (2023-2028) & ($ millions)
Table 88. Global Oral Drug Delivery Sales Forecast by Type (2023-2028) & (K Units)
Table 89. Global Oral Drug Delivery Sales Market Share Forecast by Type (2023-2028)
Table 90. Global Oral Drug Delivery Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 91. Global Oral Drug Delivery Revenue Market Share Forecast by Type (2023-2028)
Table 92. Global Oral Drug Delivery Sales Forecast by Application (2023-2028) & (K Units)
Table 93. Global Oral Drug Delivery Sales Market Share Forecast by Application (2023-2028)
Table 94. Global Oral Drug Delivery Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 95. Global Oral Drug Delivery Revenue Market Share Forecast by Application (2023-2028)
Table 96. AstraZeneca Plc. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 97. AstraZeneca Plc. Oral Drug Delivery Product Offered
Table 98. AstraZeneca Plc. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 99. AstraZeneca Plc. Main Business
Table 100. AstraZeneca Plc. Latest Developments
Table 101. Mylan N.V. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 102. Mylan N.V. Oral Drug Delivery Product Offered
Table 103. Mylan N.V. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 104. Mylan N.V. Main Business
Table 105. Mylan N.V. Latest Developments
Table 106. Sanofi Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 107. Sanofi Oral Drug Delivery Product Offered
Table 108. Sanofi Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 109. Sanofi Main Business
Table 110. Sanofi Latest Developments
Table 111. F. Hoffman-La-Roche Ltd. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 112. F. Hoffman-La-Roche Ltd. Oral Drug Delivery Product Offered
Table 113. F. Hoffman-La-Roche Ltd. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 114. F. Hoffman-La-Roche Ltd. Main Business
Table 115. F. Hoffman-La-Roche Ltd. Latest Developments
Table 116. Bristol-Myers Squibb Company Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 117. Bristol-Myers Squibb Company Oral Drug Delivery Product Offered
Table 118. Bristol-Myers Squibb Company Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 119. Bristol-Myers Squibb Company Main Business
Table 120. Bristol-Myers Squibb Company Latest Developments
Table 121. Sun Pharmaceuticals Industries Ltd Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 122. Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Product Offered
Table 123. Sun Pharmaceuticals Industries Ltd Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 124. Sun Pharmaceuticals Industries Ltd Main Business
Table 125. Sun Pharmaceuticals Industries Ltd Latest Developments
Table 126. Abbott Laboratories Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 127. Abbott Laboratories Oral Drug Delivery Product Offered
Table 128. Abbott Laboratories Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 129. Abbott Laboratories Main Business
Table 130. Abbott Laboratories Latest Developments
Table 131. Merck & Co. Inc. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 132. Merck & Co. Inc. Oral Drug Delivery Product Offered
Table 133. Merck & Co. Inc. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 134. Merck & Co. Inc. Main Business
Table 135. Merck & Co. Inc. Latest Developments
Table 136. Novartis AG Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 137. Novartis AG Oral Drug Delivery Product Offered
Table 138. Novartis AG Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 139. Novartis AG Main Business
Table 140. Novartis AG Latest Developments
Table 141. Pfizer Inc. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 142. Pfizer Inc. Oral Drug Delivery Product Offered
Table 143. Pfizer Inc. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 144. Pfizer Inc. Main Business
Table 145. Pfizer Inc. Latest Developments
Table 146. Vectura Group plc. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 147. Vectura Group plc. Oral Drug Delivery Product Offered
Table 148. Vectura Group plc. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 149. Vectura Group plc. Main Business
Table 150. Vectura Group plc. Latest Developments
Table 151. GlaxoSmithKline plc. Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 152. GlaxoSmithKline plc. Oral Drug Delivery Product Offered
Table 153. GlaxoSmithKline plc. Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 154. GlaxoSmithKline plc. Main Business
Table 155. GlaxoSmithKline plc. Latest Developments
Table 156. Johnson & Johnson Services, Inc Basic Information, Oral Drug Delivery Manufacturing Base, Sales Area and Its Competitors
Table 157. Johnson & Johnson Services, Inc Oral Drug Delivery Product Offered
Table 158. Johnson & Johnson Services, Inc Oral Drug Delivery Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)
Table 159. Johnson & Johnson Services, Inc Main Business
Table 160. Johnson & Johnson Services, Inc Latest Developments
List of Figures
Figure 1. Picture of Oral Drug Delivery
Figure 2. Oral Drug Delivery Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Oral Drug Delivery Sales Growth Rate 2017-2028 (K Units)
Figure 7. Global Oral Drug Delivery Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Oral Drug Delivery Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Diffusion Controlled Release System
Figure 10. Product Picture of Dissolution Controlled Release System
Figure 11. Product Picture of Ion Exchange Resins Controlled Release
Figure 12. Product Picture of Hydro-dynamically Balanced Drug Delivery System
Figure 13. Product Picture of Osmotically Controlled Release System
Figure 14. Product Picture of Dissolution & Diffusion Controlled Release System
Figure 15. Global Oral Drug Delivery Sales Market Share by Type in 2021
Figure 16. Global Oral Drug Delivery Revenue Market Share by Type (2017-2022)
Figure 17. Oral Drug Delivery Consumed in Hospitals
Figure 18. Global Oral Drug Delivery Market: Hospitals (2017-2022) & (K Units)
Figure 19. Oral Drug Delivery Consumed in Clinics
Figure 20. Global Oral Drug Delivery Market: Clinics (2017-2022) & (K Units)
Figure 21. Oral Drug Delivery Consumed in Other
Figure 22. Global Oral Drug Delivery Market: Other (2017-2022) & (K Units)
Figure 23. Global Oral Drug Delivery Sales Market Share by Application (2017-2022)
Figure 24. Global Oral Drug Delivery Revenue Market Share by Application in 2021
Figure 25. Oral Drug Delivery Revenue Market by Company in 2021 ($ Million)
Figure 26. Global Oral Drug Delivery Revenue Market Share by Company in 2021
Figure 27. Global Oral Drug Delivery Sales Market Share by Geographic Region (2017-2022)
Figure 28. Global Oral Drug Delivery Revenue Market Share by Geographic Region in 2021
Figure 29. Global Oral Drug Delivery Sales Market Share by Region (2017-2022)
Figure 30. Global Oral Drug Delivery Revenue Market Share by Country/Region in 2021
Figure 31. Americas Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 32. Americas Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 33. APAC Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 34. APAC Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 35. Europe Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 36. Europe Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 37. Middle East & Africa Oral Drug Delivery Sales 2017-2022 (K Units)
Figure 38. Middle East & Africa Oral Drug Delivery Revenue 2017-2022 ($ Millions)
Figure 39. Americas Oral Drug Delivery Sales Market Share by Country in 2021
Figure 40. Americas Oral Drug Delivery Revenue Market Share by Country in 2021
Figure 41. United States Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 42. Canada Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 43. Mexico Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 44. Brazil Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 45. APAC Oral Drug Delivery Sales Market Share by Region in 2021
Figure 46. APAC Oral Drug Delivery Revenue Market Share by Regions in 2021
Figure 47. China Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 48. Japan Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 49. South Korea Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 50. Southeast Asia Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 51. India Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 52. Australia Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 53. Europe Oral Drug Delivery Sales Market Share by Country in 2021
Figure 54. Europe Oral Drug Delivery Revenue Market Share by Country in 2021
Figure 55. Germany Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 56. France Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 57. UK Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 58. Italy Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 59. Russia Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 60. Middle East & Africa Oral Drug Delivery Sales Market Share by Country in 2021
Figure 61. Middle East & Africa Oral Drug Delivery Revenue Market Share by Country in 2021
Figure 62. Egypt Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 63. South Africa Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 64. Israel Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 65. Turkey Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 66. GCC Country Oral Drug Delivery Revenue Growth 2017-2022 ($ Millions)
Figure 67. Manufacturing Cost Structure Analysis of Oral Drug Delivery in 2021
Figure 68. Manufacturing Process Analysis of Oral Drug Delivery
Figure 69. Industry Chain Structure of Oral Drug Delivery
Figure 70. Channels of Distribution
Figure 71. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...